Generation of an induced pluripotent stem cell (iPSC) line of a Marfan syndrome patient with a pathogenic FBN1 c.5372G > A (p.Cys1791Tyr) variant
- PMID: 36801568
- DOI: 10.1016/j.scr.2023.103050
Generation of an induced pluripotent stem cell (iPSC) line of a Marfan syndrome patient with a pathogenic FBN1 c.5372G > A (p.Cys1791Tyr) variant
Abstract
Marfan syndrome (MFS) is a connective tissue disorder with pleiotropic manifestations in the ocular, skeletal and cardiovascular system. Ruptured aortic aneurysms in MFS patients are associated with high mortality rates. MFS is typically caused by pathogenic variants in the fibrillin-1 (FBN1) gene. Here, we report a generated induced pluripotent cell (iPSC) line of a MFS patient with a FBN1 c.5372G > A (p.Cys1791Tyr) variant. For that, skin fibroblasts of a MFS patient carrying a FBN1 c.5372G > A (p.Cys1791Tyr) variant were successfully reprogrammed into iPSCs using the CytoTune™-iPS 2.0 Sendai Kit (Invitrogen). The iPSCs showed a normal karyotype, expressed pluripotency markers, were able to differentiate into three germ layers and carried the original genotype.
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
A generated induced pluripotent stem cell (iPSC) line (CMGANTi005-A) of a Marfan syndrome patient with an FBN1 c.7754T > C (p.Ile2585Thr) variation.Stem Cell Res. 2023 Mar;67:103032. doi: 10.1016/j.scr.2023.103032. Epub 2023 Jan 23. Stem Cell Res. 2023. PMID: 36708686
-
Generation of a human iPSC line from a patient with Marfan syndrome caused by mutation in FBN1.Stem Cell Res. 2019 Apr;36:101414. doi: 10.1016/j.scr.2019.101414. Epub 2019 Feb 27. Stem Cell Res. 2019. PMID: 30870686
-
Reprogramming of a human induced pluripotent stem cell line from a Marfan syndrome patient harboring a heterozygous mutation of c.2939G > A in FBN1 gene.Stem Cell Res. 2021 Mar;51:102163. doi: 10.1016/j.scr.2021.102163. Epub 2021 Jan 8. Stem Cell Res. 2021. PMID: 33450697
-
A novel fibrillin-1 gene missense mutation associated with neonatal Marfan syndrome: a case report and review of the mutation spectrum.BMC Pediatr. 2016 Apr 30;16:60. doi: 10.1186/s12887-016-0598-6. BMC Pediatr. 2016. PMID: 27138491 Free PMC article. Review.
-
Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies.Hum Mutat. 2002 Sep;20(3):153-61. doi: 10.1002/humu.10113. Hum Mutat. 2002. PMID: 12203987 Review.
Cited by
-
Human stem cell models for Marfan syndrome: a brief overview of the rising star in disease modelling.Front Cell Dev Biol. 2025 Jan 3;12:1498669. doi: 10.3389/fcell.2024.1498669. eCollection 2024. Front Cell Dev Biol. 2025. PMID: 39830211 Free PMC article. Review.
-
An engineered in vitro model of the human myotendinous junction.Acta Biomater. 2024 May;180:279-294. doi: 10.1016/j.actbio.2024.04.007. Epub 2024 Apr 10. Acta Biomater. 2024. PMID: 38604466 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials